Market revenue in 2022 | USD 665.6 million |
Market revenue in 2030 | USD 948.3 million |
Growth rate | 4.5% (CAGR from 2022 to 2030) |
Largest segment | Cdna synthesis & conversion |
Fastest growing segment | Data Analysis & Interpretation |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sample Collection, Purification, CDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation |
Key market players worldwide | Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene expression market will help companies and investors design strategic landscapes.
Cdna synthesis & conversion was the largest segment with a revenue share of 26.97% in 2022. Horizon Databook has segmented the Germany gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
Technological advances, along with presence of companies offering tools and services that support gene expression studies, are contributing to the country’s highest revenue share in the region. Key players in the country offer bioinformatics, sequencing, and technology platforms, including PCR cloning kits, expression vectors, HPLC, and others for functional screening and generation of genome and metagenome clone libraries.
Universities and academic institutes offer advanced courses and training for use of bioinformatics tools for genomic studies. This has resulted in a large number of skilled personnel and experts in the country.
In addition, emerging facets of gene expression profiling allows understanding of various diseases at transcriptional levels. It is expected to provide highefficiency treatments by enabling the availability of highly personalized medicines based on an individual’s gene expression patterns.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany gene expression market, including forecasts for subscribers. This country databook contains high-level insights into Germany gene expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account